[
  {
    "ts": null,
    "headline": "Biogen Inc. stock outperforms competitors despite losses on the day",
    "summary": "Biogen Inc. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=240b485c7141033328c9a80affc35bbdb00e7b6d546fc4f6635d13a9e5ad03b8",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743525000,
      "headline": "Biogen Inc. stock outperforms competitors despite losses on the day",
      "id": 133684591,
      "image": "",
      "related": "BIIB",
      "source": "MarketWatch",
      "summary": "Biogen Inc. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=240b485c7141033328c9a80affc35bbdb00e7b6d546fc4f6635d13a9e5ad03b8"
    }
  },
  {
    "ts": null,
    "headline": "Biogen (NASDAQ:BIIB) sheds US$697m, company earnings and investor returns have been trending downwards for past five years",
    "summary": "Generally speaking long term investing is the way to go. But that doesn't mean long term investors can avoid big...",
    "url": "https://finnhub.io/api/news?id=c16c01d50792902a01ab1906497063f81c33534d63e916bb8d83a321205dd036",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743502336,
      "headline": "Biogen (NASDAQ:BIIB) sheds US$697m, company earnings and investor returns have been trending downwards for past five years",
      "id": 133646017,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Generally speaking long term investing is the way to go. But that doesn't mean long term investors can avoid big...",
      "url": "https://finnhub.io/api/news?id=c16c01d50792902a01ab1906497063f81c33534d63e916bb8d83a321205dd036"
    }
  },
  {
    "ts": null,
    "headline": "Biogen : Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission",
    "summary": "TOKYO and CAMBRIDGE, Mass., April 1, 2025 - Eisai Co., Ltd. and Biogen Inc. announced today an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as a...",
    "url": "https://finnhub.io/api/news?id=ae46f2afbff3a760f211cf1693915b363b959249ca3d1990122a67f3962b3a45",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743487996,
      "headline": "Biogen : Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease by the European Commission",
      "id": 133633957,
      "image": "",
      "related": "BIIB",
      "source": "Finnhub",
      "summary": "TOKYO and CAMBRIDGE, Mass., April 1, 2025 - Eisai Co., Ltd. and Biogen Inc. announced today an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as a...",
      "url": "https://finnhub.io/api/news?id=ae46f2afbff3a760f211cf1693915b363b959249ca3d1990122a67f3962b3a45"
    }
  }
]